Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 18, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Liver-specific contrast agents.

Dow-Mu Koh1

  • 1Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. dow-mu.koh@icr.ac.uk

Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|October 2, 2012
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

European urology·2026
Same author

Does <sup>18</sup>F-sodium fluoride PET/CT have a role in the assessment of response to <sup>223</sup>Ra therapy in men with prostatic bone metastases?

European journal of nuclear medicine and molecular imaging·2026
Same author

Apparent diffusion coefficient and kurtosis parameters show early response to anti-angiogenic therapy in patients with colorectal liver metastases.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same author

Whole-Body MR Imaging in Cancer Detection: Protocols, Practices, and Future Directions.

Radiologic clinics of North America·2026
Same author

Magnetic resonance imaging thoracic organ-at-risk atlas for radiation oncology.

Physics and imaging in radiation oncology·2026
Same author

CT and MR evaluation of main pancreatic duct dilation: A radiologist's guide to differentiating benign from malignant causes.

European journal of radiology·2026
Same journal

When PSMA is not enough: the diagnostic blind spots of PSMA PET/CT and the added value of [¹⁸F]FDG in high-risk prostate cancer: dual-tracer cohort study.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same journal

Evaluation of audiovisual and auditory interventions on exam anxiety during whole-body magnetic resonance imaging in cancer patients: a quasi-experimental study.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same journal

Predictive imaging biomarkers on whole-body diffusion-weighted MRI (WB-DWMRI) and [<sup>68</sup>Ga]GaPSMA-PET/CT for [<sup>177</sup>Lu]LuPSMA therapy in metastatic prostate cancer (mCRPC).

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same journal

Correction to: [¹⁸F]PSMA-1007 and [¹⁸F]FDG PET/CT in patients with metastatic triple-negative breast cancer: a prospective head-to-head comparison and assessment of PSMA-targeted radioligand therapy applicability.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same journal

MRI-based perfusion-diffusion habitat analysis for characterizing intratumoral heterogeneity in rectal adenocarcinoma.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same journal

Survival prediction of <sup>18</sup>F-FDG PET/CT in pediatric patients with recurrent neuroblastoma.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
See all related articles

Magnetic resonance imaging (MRI) aids cancer diagnosis and treatment assessment. Liver-specific contrast agents offer improved evaluation beyond standard MRI techniques for better disease detection and characterization.

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Background:

  • Magnetic resonance imaging (MRI) is a vital tool in cancer management.
  • Standard MRI protocols include non-contrast T1/T2-weighted and gadolinium-enhanced T1-weighted imaging.
  • These methods are foundational for liver assessment in cancer patients.

Purpose of the Study:

  • To highlight the growing importance of liver-specific contrast agents in oncology.
  • To discuss the advantages of these agents over traditional MRI techniques for liver evaluation.
  • To emphasize their role in disease detection, characterization, and treatment response assessment.

Main Methods:

  • Review of current literature on MRI techniques in cancer diagnosis.
  • Analysis of the role of non-contrast and gadolinium-enhanced MRI for liver assessment.

More Related Videos

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Successful Orthotopic Liver Transplantation in Mice Utilizing Microcomputed Tomography Angiography
09:23

Successful Orthotopic Liver Transplantation in Mice Utilizing Microcomputed Tomography Angiography

Published on: September 22, 2023

Related Experiment Videos

Last Updated: May 18, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Successful Orthotopic Liver Transplantation in Mice Utilizing Microcomputed Tomography Angiography
09:23

Successful Orthotopic Liver Transplantation in Mice Utilizing Microcomputed Tomography Angiography

Published on: September 22, 2023

  • Evaluation of emerging data on liver-specific contrast agents.

    • Main Results:

    • Standard MRI sequences are effective but have limitations.
    • Liver-specific contrast agents demonstrate enhanced capabilities for liver lesion evaluation.
    • These agents offer improved accuracy in disease detection and characterization.

    Conclusions:

    • Liver-specific contrast agents represent a significant advancement in oncologic imaging.
    • Their use can refine the assessment of liver disease in cancer patients.
    • Further integration of these agents is recommended for comprehensive liver evaluation.